RISPERIDONE SANDOZ 4 mg, orodispersible tablet 28 tablets
Active ingredients: Risperidone
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Orodispersible tablet28 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- RISPERIDONE SANDOZ 4 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- 28 plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Feb 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65225870CIP74917534CIP133400949175345Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISPÉRIDONEcomprimé | 4 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.